Common Contracts

NEMUS BIOSCIENCE, INC. October 26, 2016

Lock-Up Agreement • October 28th, 2016 • Nemus Bioscience, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Lock-Up Agreement
• Filed
  October 28th, 2016
• Company
  Nemus Bioscience, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Lock-Up Agreement is being delivered to you in connection with the Securities Purchase Agreement (the "Purchase Agreement"), dated as of October 26, 2016 by and among Nemus Bioscience, Inc. (the "Company") and the investors party thereto (the "Buyers"), with respect to the issuance of shares of Series C Convertible Preferred Stock of the Company, par value $0.001 per share. Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement.

NEMUS BIOSCIENCE, INC. October 26, 2016

Lock-Up Agreement • October 27th, 2016 • Nemus Bioscience, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Lock-Up Agreement
• Filed
  October 27th, 2016
• Company
  Nemus Bioscience, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Lock-Up Agreement is being delivered to you in connection with the Securities Purchase Agreement (the "Purchase Agreement"), dated as of October 26, 2016 by and among Nemus Bioscience, Inc. (the "Company") and the investors party thereto (the "Buyers"), with respect to the issuance of shares of Series C Convertible Preferred Stock of the Company, par value $0.001 per share. Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement.

NEMUS BIOSCIENCE, INC.

Lock-Up Agreement • August 21st, 2015 • Nemus Bioscience, Inc. • Trucking (no local) • New York

• Contract Type
  Lock-Up Agreement
• Filed
  August 21st, 2015
• Company
  Nemus Bioscience, Inc.
• Industry
  Trucking (no local)
• Jurisdiction
  New York

This Lock-Up Agreement is being delivered to you in connection with the Securities Purchase Agreement (the "Purchase Agreement"), dated as of August 19, 2015 by and among Nemus Bioscience, Inc. (the "Company") and the investors party thereto (the "Buyers"), with respect to the issuance of (i) shares of Series B Convertible Preferred Stock of the Company, par value $0.001 per share, which will be convertible into shares of common stock of the Company, par value $0.001 per share (the "Common Stock") pursuant to the terms of the Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock and (ii) Warrants which will be exercisable to purchase Common Stock. Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement.